[go: up one dir, main page]

AR035986A1 - Uso de derivados anti-convulsivos para la manufactura de un medicamento util para el tratamiento del temblor esencial - Google Patents

Uso de derivados anti-convulsivos para la manufactura de un medicamento util para el tratamiento del temblor esencial

Info

Publication number
AR035986A1
AR035986A1 ARP000100658A ARP000100658A AR035986A1 AR 035986 A1 AR035986 A1 AR 035986A1 AR P000100658 A ARP000100658 A AR P000100658A AR P000100658 A ARP000100658 A AR P000100658A AR 035986 A1 AR035986 A1 AR 035986A1
Authority
AR
Argentina
Prior art keywords
manufacture
treatment
derivatives
convulsive
medicinal product
Prior art date
Application number
ARP000100658A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR035986A1 publication Critical patent/AR035986A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Uso de derivados anticonvulsivos de la fórmula (1) para la manufactura de un medicamento útil para el tratamiento del temblor esencial, en donde X, R1, R2, R3, R4 y R5 tienen el significado dado en la memoria descriptiva.
ARP000100658A 1999-02-17 2000-02-16 Uso de derivados anti-convulsivos para la manufactura de un medicamento util para el tratamiento del temblor esencial AR035986A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12041399P 1999-02-17 1999-02-17

Publications (1)

Publication Number Publication Date
AR035986A1 true AR035986A1 (es) 2004-08-04

Family

ID=22390119

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100658A AR035986A1 (es) 1999-02-17 2000-02-16 Uso de derivados anti-convulsivos para la manufactura de un medicamento util para el tratamiento del temblor esencial

Country Status (24)

Country Link
US (1) US6214867B1 (es)
EP (1) EP1158950B1 (es)
JP (1) JP2002539088A (es)
KR (1) KR100664612B1 (es)
CN (1) CN1433306A (es)
AR (1) AR035986A1 (es)
AT (1) ATE316374T1 (es)
AU (1) AU779823B2 (es)
BR (1) BR0008791A (es)
CA (1) CA2362336C (es)
CZ (1) CZ295096B6 (es)
DE (1) DE60025705T2 (es)
DK (1) DK1158950T3 (es)
ES (1) ES2257288T3 (es)
HU (1) HUP0202634A3 (es)
IL (2) IL144943A0 (es)
MX (1) MXPA01008387A (es)
MY (1) MY129238A (es)
NO (1) NO20014026L (es)
NZ (1) NZ513724A (es)
TR (1) TR200103126T2 (es)
TW (1) TWI228413B (es)
WO (1) WO2000048549A2 (es)
ZA (1) ZA200107564B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082222A1 (en) * 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
CA2461539A1 (en) * 2001-09-24 2003-04-03 Faruk S. Abuzzahab, Sr. Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4981867A (en) 1989-12-08 1991-01-01 The Board Of Trustees Of The Leland Stanford Junior University Treatment of tremor using compounds that depress calcium currents in thalamic and other central nervous system neurons
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5735693A (en) * 1996-03-29 1998-04-07 Multi Lingua Ltd.. Method and device for learning a foreign language
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування

Also Published As

Publication number Publication date
CA2362336C (en) 2005-04-12
WO2000048549A3 (en) 2002-04-04
CN1433306A (zh) 2003-07-30
EP1158950B1 (en) 2006-01-25
MXPA01008387A (es) 2003-06-06
NZ513724A (en) 2004-01-30
AU779823B2 (en) 2005-02-10
ZA200107564B (en) 2002-12-13
NO20014026D0 (no) 2001-08-17
CZ295096B6 (cs) 2005-05-18
WO2000048549A2 (en) 2000-08-24
JP2002539088A (ja) 2002-11-19
DE60025705T2 (de) 2006-08-24
MY129238A (en) 2007-03-30
EP1158950A1 (en) 2001-12-05
IL144943A0 (en) 2002-06-30
KR20010112272A (ko) 2001-12-20
IL144943A (en) 2006-08-20
DE60025705D1 (de) 2006-04-13
ATE316374T1 (de) 2006-02-15
CZ20013011A3 (cs) 2002-06-12
HUP0202634A3 (en) 2005-02-28
DK1158950T3 (da) 2006-04-24
TR200103126T2 (tr) 2002-07-22
KR100664612B1 (ko) 2007-01-04
AU3364800A (en) 2000-09-04
US6214867B1 (en) 2001-04-10
NO20014026L (no) 2001-10-17
HUP0202634A2 (hu) 2002-11-28
CA2362336A1 (en) 2000-08-24
BR0008791A (pt) 2005-04-05
TWI228413B (en) 2005-03-01
ES2257288T3 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
GEP20022653B (en) Processes and Intermediates for Preparing Anti-Cancer Compounds
GEP20053488B (en) Novel Spiro Compounds
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
TR199800019T1 (xx) Trombosit topaklanmas�n� �nleyici yeni maddeler.
GEP20063799B (en) Tropane derivatives useful in therapy
SE9904505D0 (sv) Novel compounds
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
SE9504661D0 (sv) New compounds
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
GEP20032999B (en) 1-Heterocycle Substituted Diarylamines
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
ATE495793T1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
SE9702564D0 (sv) New compounds
ATE243196T1 (de) Piperidine und pyrrolidine
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
NO20020282D0 (no) Nytt difenylpiperidinderivat
ATE360428T1 (de) Analgetisches arzneimittel
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
PT1147105E (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente activo e sua utilizacao no tratamento de doencas vasculares
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
AR035986A1 (es) Uso de derivados anti-convulsivos para la manufactura de un medicamento util para el tratamiento del temblor esencial

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FA Abandonment or withdrawal